Skip to main content
THC logo

Tenet Healthcare Corporation (THC) Stock: Price, Forecast & Analyst Target

Tenet Healthcare Corporation (THC) — MoonshotScore 94/100 (Exceptional band), calculated Nov 18, 2026. Price $271.34 (-3.80%), as of the Nov 18, 2026 trading session; market cap $21.6B.

Educational signal · not a buy or sell recommendation · How to read this

$271.34 −$10.73 (-3.80%) Market Cap $21.6B

Tenet Healthcare Corporation · THC · NYSE · Healthcare · Medical - Care Facilities

Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered): Tenet Healthcare earns from acute hospital care, ambulatory procedures and Conifer’s administrative services for healthcare organizations. Its durability depends on whether operational gains and greater capital deployment into USPI can sustain cash generation while debt remains far larger than liquid resources.

Price as of Nov 18, 2026

Key Statistics

94 of 100

MoonshotScore v2 · Tenet Healthcare (THC)

Exceptional
Business Quality Elite (86)
Financial Safety Okay (45)
Valuation Cheap (84)
Growth Durability Compounding (98)
Momentum Surging (91)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and elite growth, at a cheap price, though the balance sheet is only middling; the market is already moving on it. Business Quality: Elite; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Compounding; Momentum: Surging.

  • quarterly revenue $6.28B (Q3 FY2026, quarter ended Sep 2026)
  • EPS beat 8 of the last 8 reports
  • Altman Z 2.29 · Piotroski F 8

Helping: business quality, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for THC (57 recorded, newest six shown)
RecordedScoreBand
91Exceptional
91Exceptional
91Exceptional
91Exceptional
94Exceptional
94Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$271.34
Change on the day-3.80%
52-week range$157.58–$301.44
Market capitalisation$21.6B—
Price / earnings (trailing)8.13
Shares traded on the day1.57M
Beta (volatility vs the S&P 500)1.2

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $162, high $286, latest $271. $286 $162 high $286 Oct 17, 2025 Nov 18, 2026 · $271 $200Oct 17, 2025$206Oct 31, 2025$193Nov 14, 2025$217Nov 28, 2025$199Dec 12, 2025$201Dec 26, 2025$201Jan 9, 2026$189Jan 23, 2026$201Feb 6, 2026$230Feb 20, 2026$237Mar 6, 2026$200Mar 20, 2026$188Apr 2, 2026$197Apr 17, 2026$183May 1, 2026$197May 15, 2026$175May 29, 2026$175Jun 12, 2026$189Jun 26, 2026$204Jul 10, 2026$233Jul 24, 2026$262Aug 7, 2026$281Aug 21, 2026$265Sep 4, 2026$262Sep 18, 2026$259Oct 2, 2026$267Oct 16, 2026$273Oct 30, 2026$286Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Tenet Healthcare (THC): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Neutral
Valuation Strong
Growth Durability Strong
Momentum Strong

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Moderate
Revenue Growth Neutral
Debt/Equity Negative
ROE Strong
Gross Margin Neutral

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 16, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Tenet Healthcare (THC), and what does it report?

Short answer

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer.

Tenet is more than a hospital operator. Hospitals deliver acute and highly specialized care, ambulatory facilities handle procedures and related services outside the traditional hospital setting, and Conifer manages revenue cycles, patient communications and care-focused administrative workflows for healthcare clients.

The consolidated accounts therefore combine care delivery with contracted business-process services. Ambulatory Care and Hospital Operations sit at nearly the same reported scale, making the mix between settings as important as the consolidated revenue line.

2 · Latest results

What do the latest results show for Tenet Healthcare (THC)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $6.28B.

Revenue recovered from the prior dip and moved beyond its earlier high in the displayed quarterly series. Net result and diluted earnings also reached displayed peaks, while operating result improved without surpassing an older high; this quarterly acceleration follows an annual period when revenue advanced but net result retreated.

The latest reported result cleared revenue and earnings estimates. Earnings have repeatedly surpassed estimates across the displayed history, although revenue has been less consistent against expectations.

Management attributes the stronger outlook to fundamental operating improvements and expects those benefits to continue. It also expects exchange erosion and broader market conditions to persist, so that explanation should be treated as a claim to test against subsequent results rather than as a completed transformation.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$6.28B$1.00B$12.41 (diluted)
Q2 FY2026$5.63B$826M$9.84 (diluted)
Q1 FY2026$5.37B$702M$8.01 (diluted)
Q4 FY2025$5.53B$371M$4.22 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Tenet Healthcare (THC)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Tenet generates substantial operating cash, and recent operating inflows have exceeded capital spending. Cash conversion is not steady, however: the latest inflow fell sharply from the preceding period, and the cash balance has declined materially across the displayed window.

Reported liquidity ratios indicate coverage of current obligations, but total debt greatly exceeds cash and short-term investments. That leverage raises the importance of dependable cash conversion as Tenet directs more capital toward USPI.

Persistent exchange erosion is the clearest identified operating pressure. If operational gains fail to offset it while capital deployment continues, weaker cash conversion would leave less flexibility against the debt burden.

4 · What to check next?

What should you watch next at Tenet Healthcare (THC)?

Short answer · as of

Current published price targets run low $265.00 · high $308.00 · consensus $289.00 · median $285.00 against a quoted price of $271.34 (as of Nov 18, 2026).

At the scheduled earnings release, watch whether revenue remains near its recent high, operating profit continues to advance and earnings maintain their record of exceeding expectations. The consensus path assumes gradual revenue expansion but an uneven earnings progression, making operating performance more informative than a smooth headline growth story.

Cash deserves equal attention. A recovery in operating cash flow, stabilization of the cash balance and evidence that USPI spending is producing durable operating gains would support management’s outlook; continued cash depletion alongside heavy debt would weaken it.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Tenet Healthcare compare with its peers?

Short answer

Tenet Healthcare's score ranks 1st of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Tenet combines acute-care hospitals, ambulatory procedure sites and Conifer’s healthcare administration services. Compared with a hospital-focused operator, its procedure-site demand and administrative contract activity can diverge from conditions inside acute-care facilities.

Ambulatory Care and Hospital Operations are reported at nearly comparable scale, while Conifer adds a different revenue mechanism. That operating breadth is paired with substantial leverage, so comparisons based only on consolidated sales miss the importance of business mix and cash conversion.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Tenet Healthcare (THC) — this page$271.34$21.6B94
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$13.77 Nov 18, 2026$5.24B92 5-pillar Nov 18, 2026
Universal Health Services, Inc. (UHS) Named competitor$186.07 Nov 18, 2026$10.7B91 5-pillar Nov 18, 2026
Chemed Corporation (CHE) Same industry, near in market value$546.72 Nov 18, 2026$7.09B85 5-pillar Nov 18, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$31.71 Nov 18, 2026$4.75B85 5-pillar Nov 18, 2026
Pediatrix Medical Group, Inc. (MD) Same industry, near in market value$30.84 Nov 18, 2026$2.41B82 5-pillar Nov 18, 2026
Encompass Health Corporation (EHC) Named competitor$134.94 Nov 18, 2026$13.2B81 5-pillar Nov 18, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Same industry, near in market value$20.95 Nov 18, 2026$10.9B80 5-pillar Nov 18, 2026
HCA Healthcare, Inc. (HCA) Named competitor$476.35 Nov 18, 2026$99.5B77 5-pillar Nov 18, 2026
DaVita Inc. (DVA) Named competitor$161.75 Nov 18, 2026$10.2B76 5-pillar Nov 18, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$201.60 Nov 18, 2026$3.16B76 5-pillar Nov 18, 2026
The Ensign Group, Inc. (ENSG) Named competitor$182.98 Nov 18, 2026$10.7B74 5-pillar Nov 18, 2026
Solventum Corporation (SOLV) Same industry, near in market value$86.48 Nov 18, 2026$14.7B66 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$265.00 – $308.00
Consensus target
$289.00
Median target
$285.00

Consensus record · Captured .

Measured against a quoted price of $271.34 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 11, 2026

Transactions
38
Identified insiders
14
Purchases
0
Sales
26
Other transactions
12

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held THC in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.12%$27.32MAdded +152.3% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Tenet Healthcare (THC)?

Read these with our analysis →

What Investors Ask About Tenet Healthcare (THC) — Healthcare

The last 2 questions are answered from this page's own dated data, not from the research.

What does Tenet’s Conifer business sell?

Conifer provides revenue-cycle administration, patient communication and engagement support, and care-focused business processes to hospitals, health systems, physician practices, employers and other clients.

Why is USPI important to Tenet’s capital plan?

Management increased planned capital deployment into USPI while also raising its cash-flow outlook. The key test is whether that spending produces sustained operating improvement without adding pressure to a declining cash balance.

How do Tenet’s ambulatory centers change its hospital exposure?

Ambulatory facilities let Tenet earn from surgical and diagnostic activity outside traditional acute-care hospitals. Their reported scale is close to Hospital Operations, so Tenet’s economics cannot be read solely through hospital conditions.

What must improve for Tenet’s cash balance to stabilize?

Operating inflows need to remain comfortably above capital spending and other cash uses. Recent cash flow has covered capital expenditure, but the liquid balance has still fallen substantially while debt remains much larger.

What is the THC stock price today?

The last price recorded for Tenet Healthcare Corporation (THC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the THC price target?

The analyst consensus price target for Tenet Healthcare Corporation (THC), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 27 figures on this page — 1 from SEC filings and earnings calls, 22 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Management outlook — dated call excerpts; Cash, investments and debt; Operating cash flow by quarter (USD millions)
  • 1. What is Tenet Healthcare (THC), and what does it report?: Business description; Revenue by segment
  • 2. What do the latest results show for Tenet Healthcare (THC)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts
  • 3. What are the financial strengths and risks for Tenet Healthcare (THC)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Management outlook — dated call excerpts
  • 4. What should you watch next at Tenet Healthcare (THC)?: Next earnings report; Reported versus estimated, last 8 quarters; Analyst revenue and earnings estimates (average); Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash, investments and debt; Management outlook — dated call excerpts
  • 5. How does Tenet Healthcare compare with its peers?: Business description; Revenue by segment; Trailing twelve-month ratio set; Cash, investments and debt
  • FAQ: What does Tenet’s Conifer business sell?: Business description
  • FAQ: Why is USPI important to Tenet’s capital plan?: Management outlook — dated call excerpts; Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions)
  • FAQ: How do Tenet’s ambulatory centers change its hospital exposure?: Business description; Revenue by segment
  • FAQ: What must improve for Tenet’s cash balance to stabilize?: Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash, investments and debt
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold THC

Funds in our ETF coverage that list THC among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
Concourse Capital Focused Equity ETF (CCFE)4.93%
Texas Capital Texas Equity Index ETF (TXS)4.75%
IHF ETF3.55%
XHS ETF2.40%